Genomic insights on the potential role of the accessory genome in the emergence of a novel geographically restricted K. pneumoniae lineage as a high-risk clone
Nathália BighiiD, Fernanda S. FreitasiD, Sergio Mascarenhas MorgadoiD, Rosângela Cipriano, Ana Carolina Paulo VicenteiD, Érica Lourenço da FonsecaiD
Abstract
Klebsiella pneumoniae causes life-threatening nosocomial infections and is featured by a remarkable propensity for multidrug resistance acquisition. Infections caused by multidrug- (MDR) and extensively drug-resistant (XDR) strains lead to a limitation of therapeutic options and an increase in persistent infections, and they are usually represented by high-risk lineages. Based on these features and their relevance to global public health, most of the studies focused on such high-risk clones, and little is known about the epidemiological and evolutionary dynamics of new/geographically restricted lineages. This study aimed to unveil the antimicrobial resistance and virulence genetic repertoire of a clinical XDR K. pneumoniae (Kp199) strain belonging to geographically-restricted ST, not linked to any known clonal complex. Its intrinsic (gyrA, parC, ramR, soxR and soxS mutations) and acquired resistome agreed with the observed XDR phenotype. An extensive arsenal of both antibiotic and heavy metal resistance genes was observed, as well as genes involved with resistance to several antiseptics currently used in clinical settings. The co-occurrence of blaKPC-2 and blaNDM-1 carbapenemase genes in Kp199 was an alarming finding since it could contribute to increased carbapenem resistance. Kp199 virulome was associated with bacterial survival and replication during infections. This study raises concern about a novel, geographically restricted K. pneumoniae lineage harbouring a huge resistome and virulome, which may strongly contribute to its successful establishment as an epidemic lineage. Therefore, our findings underscore the importance of vigilant surveillance and control measures to mitigate the threat posed by the potential emergence of new high-risk pandemic clones.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- FWCI
- 0.00
- Field percentile
- 0th percentile
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Antimicrobial resistance and virulence characteristics of Klebsiella pneumoniae isolates in Kenya
A. W. Muraya, C. Kyany'a, … L. Musila·bioRxiv·Feb 1, 2022
- Genomic characterization of a pandrug-resistant Klebsiella pneumoniae belonging to the high-risk ST11 in the Brazilian Amazon region
Érica Lourenço da Fonseca, Sergio Mascarenhas Morgado, … Ana Carolina Vicente·bioRxiv·Apr 25, 2023
- International and regional spread of carbapenem-resistant Klebsiella pneumoniae in Europe
M. Budia Silva, T. Kostyanev, … EURECA/WP1B Group·bioRxiv·Sep 5, 2023
- Molecular epidemiology of carbapenem-resistant hypervirulent Klebsiella pneumoniae: Risk factors and resistance mechanism of ceftazidime/avibactam in China
Na Wang, Minghua Zhan, … Wei Zhang·Frontiers in Cellular and Infection MicrobiologyPeer-reviewed·Dec 19, 2025
- Emergence of carbapenem, beta-lactamase inhibitor and cefoxitin resistant lineages from a background of ESBL-producing Klebsiella pneumoniae and K. quasipneumoniae highlights different evolutionary mechanisms
Eva Heinz, Hasan Ejaz, … Richard A. Strugnell·Scientific ReportsPeer-reviewed·Feb 20, 2019
- Distinct evolutionary dynamics of horizontal gene transfer in drug resistant and virulent clones of Klebsiella pneumoniae
K. L. Wyres, R. R. Wick, … K. E. Holt·bioRxiv·Sep 12, 2018